Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93.1M
-
Number of holders
-
180
-
Total 13F shares, excl. options
-
81.3M
-
Shares change
-
+1.37M
-
Total reported value, excl. options
-
$1.55B
-
Value change
-
+$29.7M
-
Put/Call ratio
-
0.37
-
Number of buys
-
84
-
Number of sells
-
-80
-
Price
-
$19.08
Significant Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q3 2022
212 filings reported holding MYGN - MYRIAD GENETICS INC - Common Stock, par value $0.01 per share as of Q3 2022.
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.3M shares
of 93.1M outstanding shares and own 87.36% of the company stock.
Largest 10 shareholders include BlackRock Inc. (14.6M shares), VANGUARD GROUP INC (9.13M shares), EARNEST PARTNERS LLC (6.57M shares), WELLINGTON MANAGEMENT GROUP LLP (5.96M shares), Camber Capital Management LP (5M shares), STATE STREET CORP (4.66M shares), BANK OF AMERICA CORP /DE/ (2.85M shares), Artisan Partners Limited Partnership (2.68M shares), DIMENSIONAL FUND ADVISORS LP (2.43M shares), and DISCIPLINED GROWTH INVESTORS INC /MN (2.28M shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.